Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Opioids
21 Articles Available
Can't find what you're looking for? Try our
advanced search
.
Opioids
Analysis of Government Data Reveals Main Players in Opioid Market
PAO-M08-19-NI-013
Opioids
Statement on FDA’s Request for Information on Requiring Fixed-Quantity Blister Packaging for Certain Opioid Pain Medicines
PR-M06-19-NI-003
Opioids
Top Execs at Opioid Maker Insys Therapeutics Found Guilty of Paying Bribes
PAO-M05-19-NI-015
Partnership
Heron Therapeutics Partners with the National Academy of Medicine to Counter the Opioid Epidemic in the United States
PR-M05-19-NI-027
FDA Statement
FDA Statement on New Opioid Analgesic Labeling Changes
PR-M04-19-NI-042
Opioids
Generic Suboxone Sublingual Film Launched
PAO-M03-19-NI-004
Opioids
Statement from FDA Commissioner Scott Gottlieb, M.D. on the Agency's 2019 policy and Regulatory Agenda for Continued Action to Forcefully Address Opioid Abuse
PR-M02-19-NI-061
FDA Statement
Statement from FDA Commissioner Scott Gottlieb, M.D., on Ongoing Efforts to Secure the U.S. Supply Chain and Confront the Opioid Epidemic
PR-M02-19-NI-032
Opioids
New Study Shows Physician-Targeted Marketing is Associated with Increase in Opioid Overdose Deaths
PR-M01-19-NI-063
Opioid Dependency
Could the Opioid Epidemic Be Relieved by a Vaccine?
PAO-M12-18-NI-019
FDA Statement
Statement from FDA Commissioner Scott Gottlieb, M.D., on Agency's Approval of Dsuvia and the FDA's Future Consideration of New Opioids
PR-M11-18-NI-016
Opioids
HBI Solutions' Tool Predicts Who Is Likely to Abuse Opioids Using Medical and Social Data
PR-M07-18-NI-064
Opioids
Gottlieb Discusses Results of Online Opioid Summit
PAO-M07-18-NI-003
Opiods
Preliminary Data Suggests DENKI Pain Blockers Don’t Have Abuse Potential
PAO-M06-18-NI-008
Abuse Deterrence
Generic Firms Developing Opioids with Abuse-Deterrent Properties Have New FDA Guidance to Follow
PAO-M12-17-NI-012
Innovation
Study Reveals New Medication Options for Opioid Dependency
PAO-M11-17-NI-040
Non-Opioid
SiteOne Therapeutics Garners US Department of Defense Award
PAO-M11-17-NI-036
Information Technology
Fighting Opioid Abuse, Axial Healthcare Rolls Out New IT-based Care Platform
PAO-M10-17-NI-034
Abuse Deterrence
Fighting Prescription Drug Abuse with Demonstrated Abuse-Deterrent Formulations
PAP-Q3-17-CL-003
Drug Development
Novel Genetic Test Helps Confirm Opioid Addiction Risk
PAO-M09-17-NI-006
Clinical Trials
Bonti Announces Start of LANTERN-1 Phase 2 Clinical Study Evaluating EB-001 in Reducing Musculoskeletal Pain
PR-M08-17-NI-007
.svg)
